688356 键凯科技
已收盘 07-23 15:00:00
资讯
新帖
简况
7月23日键凯科技跌6.57%,北信瑞丰健康生活基金重仓该股
证券之星 · 07-23 16:16
7月23日键凯科技跌6.57%,北信瑞丰健康生活基金重仓该股
键凯科技大跌5.01% 北向资金增持1.50万股
智选洞察 · 07-23 13:29
键凯科技大跌5.01% 北向资金增持1.50万股
键凯科技:在研的聚乙二醇伊立替康为小细胞肺癌治疗二线用药,对标其他小细胞肺癌治疗二线药物
每日经济新闻 · 07-16
键凯科技:在研的聚乙二醇伊立替康为小细胞肺癌治疗二线用药,对标其他小细胞肺癌治疗二线药物
键凯科技(688356.SH):与康希诺合作开发的三组分LNP可授权给其他公司
格隆汇资讯 · 07-16
键凯科技(688356.SH):与康希诺合作开发的三组分LNP可授权给其他公司
键凯科技07月16日获主力加仓31万元 环比增加342.86%
自选股智能写手 · 07-16
键凯科技07月16日获主力加仓31万元 环比增加342.86%
键凯科技: 关于公司下游客户的情况,请参考公司招股说明书、定期报告及其他通过公开渠道披露的信息
证券之星 · 07-08
键凯科技: 关于公司下游客户的情况,请参考公司招股说明书、定期报告及其他通过公开渠道披露的信息
键凯科技:注射用透明质酸钠复合溶液项目临床入组已经完成,正处于随访阶段
每日经济新闻 · 07-08
键凯科技:注射用透明质酸钠复合溶液项目临床入组已经完成,正处于随访阶段
键凯科技:双聚乙二醇化是一种聚乙二醇修饰方式,使用聚乙二醇衍生物连接蛋白药物上的两个位点
证券之星 · 07-02
键凯科技:双聚乙二醇化是一种聚乙二醇修饰方式,使用聚乙二醇衍生物连接蛋白药物上的两个位点
键凯科技:累计回购约14.79万股
每日经济新闻 · 07-01
键凯科技:累计回购约14.79万股
键凯科技(688356.SH):已累计回购14.79万股公司股份
格隆汇资讯 · 07-01
键凯科技(688356.SH):已累计回购14.79万股公司股份
键凯科技:伊立替康二期论文已于去年四季度提交 目前正在等待审稿结果
每日经济新闻 · 06-24
键凯科技:伊立替康二期论文已于去年四季度提交 目前正在等待审稿结果
键凯科技:公司自主研发的聚乙二醇光引发剂属于大分子光引发剂,可与多种材料形成配方
每日经济新闻 · 06-24
键凯科技:公司自主研发的聚乙二醇光引发剂属于大分子光引发剂,可与多种材料形成配方
键凯科技:公司正在开发的新型脂质纳米递送系统,主要用于各类核酸药物及疗法的递送
每日经济新闻 · 06-24
键凯科技:公司正在开发的新型脂质纳米递送系统,主要用于各类核酸药物及疗法的递送
键凯科技:伊立替康谈判在进行中
每日经济新闻 · 06-24
键凯科技:伊立替康谈判在进行中
键凯科技:盘锦新厂已经投入运营,对公司稳定毛利率水平积极作用
每日经济新闻 · 06-24
键凯科技:盘锦新厂已经投入运营,对公司稳定毛利率水平积极作用
键凯科技:注射用交联透明质酸钠凝胶项目目前正在技术审评阶段,已进行的检查均已通过
每日经济新闻 · 06-24
键凯科技:注射用交联透明质酸钠凝胶项目目前正在技术审评阶段,已进行的检查均已通过
键凯科技:翰森制药子公司江苏豪森药业集团有限公司是公司客户
每日经济新闻 · 06-24
键凯科技:翰森制药子公司江苏豪森药业集团有限公司是公司客户
6月24日键凯科技跌6.33%,大成中证1000指数增强发起式A基金重仓该股
证券之星 · 06-24
6月24日键凯科技跌6.33%,大成中证1000指数增强发起式A基金重仓该股
6月21日键凯科技涨6.89%,大成中证1000指数增强发起式A基金重仓该股
证券之星 · 06-21
6月21日键凯科技涨6.89%,大成中证1000指数增强发起式A基金重仓该股
键凯科技:注射用交联透明质酸钠凝胶项目正在技术审评阶段,注射用透明质酸钠复合溶液项目临床入组已完成
金融界 · 06-11
键凯科技:注射用交联透明质酸钠凝胶项目正在技术审评阶段,注射用透明质酸钠复合溶液项目临床入组已完成
暂无数据
公司概况
公司名称:
北京键凯科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2020-08-26
主营业务:
北京键凯科技股份有限公司主要从事医用药用聚乙二醇及其活性衍生物的研发、生产和销售。公司主要产品为医用药用聚乙二醇及其活性衍生物。公司在聚乙二醇及其活性衍生物研发、生产、医药领域应用等技术领域处于国内领先地位,是国内外为数不多能进行高纯度和低分散度的医用药用聚乙二醇及活性衍生物工业化生产的公司之一,填补了国内长期缺乏规模化生产高质量的医用药用聚乙二醇及其衍生物这一空白,是全球市场的主要新兴参与者。
发行价格:
41.18
{"stockData":{"symbol":"688356","market":"SH","secType":"STK","nameCN":"键凯科技","latestPrice":57.3,"timestamp":1721718000000,"preClose":61.33,"halted":0,"volume":513292,"delay":0,"floatShares":60614700,"shares":60614700,"eps":1.3712,"marketStatus":"已收盘","marketStatusCode":5,"change":-4.03,"latestTime":"07-23 15:00:00","open":61.33,"high":61.33,"low":57.27,"amount":30268900,"amplitude":0.0662,"askPrice":57.31,"askSize":4,"bidPrice":57.3,"bidSize":98,"shortable":0,"etf":0,"ttmEps":1.3712,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"adjPreClose":61.33,"symbolType":"stock_kcb","openAndCloseTimeList":[[1721698200000,1721705400000],[1721710800000,1721718000000]],"highLimit":67.46,"lowLimit":55.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":60614700,"pbRate":2.7,"roa":"--","roe":"1.13%","epsLYR":1.92,"committee":0.773333,"marketValue":3473000000,"floatMarketCap":3473000000,"peRate":41.788216,"changeRate":-0.0657,"turnoverRate":0.0085,"status":1,"afterMarket":{"amount":0,"volume":0,"close":57.3,"buyVolume":0,"sellVolume":0,"time":1721720037153,"indexStatus":"已收盘 07-23 15:30:00","preClose":61.33}},"requestUrl":"/m/hq/s/688356/tweets","defaultTab":"tweets","newsList":[{"id":"2453707528","title":"7月23日键凯科技跌6.57%,北信瑞丰健康生活基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453707528","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453707528?lang=zh_cn&edition=full","pubTime":"2024-07-23 16:16","pubTimestamp":1721722580,"startTime":"0","endTime":"0","summary":"证券之星消息,7月23日键凯科技跌6.57%,收盘报57.3元,换手率0.85%,成交量5133.0手,成交额3026.89万元。重仓键凯科技的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家;过去90天内机构目标均价为100.0。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为北信瑞丰健康生活。北信瑞丰健康生活目前规模为0.88亿元,最新净值0.839,较上一交易日上涨2.32%,近一年下跌29.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300029566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2453777237","title":"键凯科技大跌5.01% 北向资金增持1.50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453777237","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453777237?lang=zh_cn&edition=full","pubTime":"2024-07-23 13:29","pubTimestamp":1721712547,"startTime":"0","endTime":"0","summary":"07月23日,键凯科技股价大幅下跌,截至13点29分,键凯科技下跌5.01%,报58.26元/股,失守60元整数关口,成交2104万元,换手率0.58%,振幅5.01%。资金动向截止发稿,键凯科技获得主力净流出368万元,其中超大单流出418万元,大单流入50万元。北向资金方面,键凯科技07月22日获得北向资金增持1.50万股,截至07月22日,北向资金当前共持有键凯科技20.35万股,市值1185万元,持股占流通股比为0.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723132929af938efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723132929af938efb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2451952708","title":"键凯科技:在研的聚乙二醇伊立替康为小细胞肺癌治疗二线用药,对标其他小细胞肺癌治疗二线药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2451952708","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451952708?lang=zh_cn&edition=full","pubTime":"2024-07-16 16:03","pubTimestamp":1721117035,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问公司的在研的PEG伊立替康三期目前在市场上有没有其他竞品参与竞争?比如单抗,双抗对小细胞肺癌额治疗?公司的PEG伊立替康的优势在哪里?键凯科技(688356.SH)7月16日在投资者互动平台表示,公司在研的聚乙二醇伊立替康为小细胞肺癌治疗二线用药,对标其他小细胞肺癌治疗二线药物。关于聚乙二醇伊立替康用于治疗小细胞肺癌的疗效情况,请参考公司《关于自愿披露聚乙二醇伊立替康用于治疗小细胞肺癌完成II期临床试验数据分析的公告》(公告编号2023-038)。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071616041695c60da6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071616041695c60da6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2451951722","title":"键凯科技(688356.SH):与康希诺合作开发的三组分LNP可授权给其他公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2451951722","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451951722?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:35","pubTimestamp":1721115331,"startTime":"0","endTime":"0","summary":"格隆汇7月16日丨键凯科技(688356.SH)在投资者互动平台表示,公司与康希诺合作开发的三组分LNP可授权给其他公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161535389f546cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161535389f546cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","BK1574","BK1161","688356","06185","688185"],"gpt_icon":0},{"id":"2451782959","title":"键凯科技07月16日获主力加仓31万元 环比增加342.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451782959","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451782959?lang=zh_cn&edition=full","pubTime":"2024-07-16 15:18","pubTimestamp":1721114336,"startTime":"0","endTime":"0","summary":"07月16日, 键凯科技股价涨0.87%,报收59.30元,成交金额1008万元,换手率0.28%,振幅3.40%,量比0.64。键凯科技今日主力资金净流入31万元,连续3日净流入,上一交易日主力净流入7万元,今日环比增加342.86%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为70.00%,平均涨幅为3.28%。该股近5个交易日上涨3.47%,主力资金累计净流出34万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出1616万元,其中净流出天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161530499f54653f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161530499f54653f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2449729079","title":"键凯科技:\n关于公司下游客户的情况,请参考公司招股说明书、定期报告及其他通过公开渠道披露的信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2449729079","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449729079?lang=zh_cn&edition=full","pubTime":"2024-07-08 17:01","pubTimestamp":1720429292,"startTime":"0","endTime":"0","summary":"证券之星消息,键凯科技07月08日在投资者关系平台上答复投资者关心的问题。关于公司新申报的创新3类医疗器械产品,请参考公司《关于自愿披露注射用交联透明质酸钠凝胶注册申请获得受理的公告》披露的信息。关于公司下游客户的情况,请参考公司招股说明书、定期报告及其他通过公开渠道披露的信息。尽快产生现金流,望公司采纳键凯科技董秘:尊敬的投资者您好,感谢您对公司的关注与建议。具体进展情况以公司后续相关公告为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800023371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2449289947","title":"键凯科技:注射用透明质酸钠复合溶液项目临床入组已经完成,正处于随访阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2449289947","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449289947?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:00","pubTimestamp":1720425628,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:目前已到了三季度,请问公司的长效水针是不是还是按照计划,今年4季度上报医疗器械产品注册?键凯科技(688356.SH)7月8日在投资者互动平台表示,注射用透明质酸钠复合溶液项目临床入组已经完成,正处于随访阶段。具体进展情况以公司后续相关公告为准。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708160057958f0c47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708160057958f0c47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2448136939","title":"键凯科技:双聚乙二醇化是一种聚乙二醇修饰方式,使用聚乙二醇衍生物连接蛋白药物上的两个位点","url":"https://stock-news.laohu8.com/highlight/detail?id=2448136939","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448136939?lang=zh_cn&edition=full","pubTime":"2024-07-02 18:02","pubTimestamp":1719914529,"startTime":"0","endTime":"0","summary":"证券之星消息,键凯科技07月02日在投资者关系平台上答复投资者关心的问题。双聚乙二醇化是一种聚乙二醇修饰方式,使用聚乙二醇衍生物连接蛋白药物上的两个位点。目前公司正在进行伊立替康三期临床前的系列准备工作,再次感谢您对键凯科技的关注。键凯科技秉承“以材料创新引领生物医药创新”的宗旨,注重技术研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021803439565bd05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407021803439565bd05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2448964782","title":"键凯科技:累计回购约14.79万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448964782","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448964782?lang=zh_cn&edition=full","pubTime":"2024-07-01 17:21","pubTimestamp":1719825664,"startTime":"0","endTime":"0","summary":"每经AI快讯,键凯科技 7月1日晚间发布公告称,截至2024年6月30日,公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购公司股份约14.79万股,占公司总股本的比例为0.244%,回购成交的最高价为75.05元/股,最低价为62.85元/股,支付的资金总额为人民币约1050万元。2023年1至12月份,键凯科技的营业收入构成为:医用药用合成新材料占比100.0%。截至发稿,键凯科技市值为37亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011721239eebe1a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011721239eebe1a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2448961836","title":"键凯科技(688356.SH):已累计回购14.79万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2448961836","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448961836?lang=zh_cn&edition=full","pubTime":"2024-07-01 17:08","pubTimestamp":1719824890,"startTime":"0","endTime":"0","summary":"格隆汇7月1日丨键凯科技(688356.SH)公布,截至2024年6月30日,公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购公司股份14.7914万股,占公司总股本的比例为0.2440%,回购成交的最高价为75.05元/股,最低价为62.85元/股,支付的资金总额为人民币10,500,337.30元(不含印花税、交易佣金等交易费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011709189eebcc87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407011709189eebcc87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2445040031","title":"键凯科技:伊立替康二期论文已于去年四季度提交 目前正在等待审稿结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2445040031","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445040031?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:56","pubTimestamp":1719219410,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问伊立替康2期论文发表了吗?键凯科技(688356.SH)6月24日在投资者互动平台表示,伊立替康二期论文已于去年四季度提交,目前正在等待审稿结果。文章来源:每日经济新闻原标题:键凯科技:伊立替康二期论文已于去年四季度提交,目前正在等待审稿结果","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241659239f5f2643&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241659239f5f2643&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2445040038","title":"键凯科技:公司自主研发的聚乙二醇光引发剂属于大分子光引发剂,可与多种材料形成配方","url":"https://stock-news.laohu8.com/highlight/detail?id=2445040038","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445040038?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:50","pubTimestamp":1719219006,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:尊敬的董秘,咱们聚乙二醇的光引发剂,在其他树脂3D打印中可以应用吗键凯科技(688356.SH)6月24日在投资者互动平台表示,公司自主研发的聚乙二醇光引发剂属于大分子光引发剂,可与多种材料形成配方。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241650279f5f1cec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241650279f5f1cec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2445040034","title":"键凯科技:公司正在开发的新型脂质纳米递送系统,主要用于各类核酸药物及疗法的递送","url":"https://stock-news.laohu8.com/highlight/detail?id=2445040034","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445040034?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:49","pubTimestamp":1719218990,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:公司的美国官网发布了公司的创新研究创新脂质纳米粒,请教这个技术的主要用途是什么?键凯科技(688356.SH)6月24日在投资者互动平台表示,公司正在开发的新型脂质纳米递送系统,主要用于各类核酸药物及疗法的递送,具有自主知识产权优势,目前与该技术关联的客户项目尚处于早期研发阶段。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241650199f5f1cc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241650199f5f1cc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2445904003","title":"键凯科技:伊立替康谈判在进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2445904003","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445904003?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:45","pubTimestamp":1719218758,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问目前与公司谈判伊立替康三期的是国内企业还是外资企业?键凯科技(688356.SH)6月24日在投资者互动平台表示,伊立替康谈判在进行中,具体进展情况以公司后续相关公告为准。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241646449f5f19b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241646449f5f19b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2445400330","title":"键凯科技:盘锦新厂已经投入运营,对公司稳定毛利率水平积极作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2445400330","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445400330?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:44","pubTimestamp":1719218692,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问公司是不是计划用盘锦的产能打价格战?键凯科技(688356.SH)6月24日在投资者互动平台表示,盘锦新厂已经投入运营,对公司稳定毛利率水平积极作用。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241646129f5f1922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241646129f5f1922&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2445047077","title":"键凯科技:注射用交联透明质酸钠凝胶项目目前正在技术审评阶段,已进行的检查均已通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2445047077","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445047077?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:43","pubTimestamp":1719218618,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问公司注射用交联透明质酸钠凝胶产品注册评审到哪一步了?键凯科技(688356.SH)6月24日在投资者互动平台表示,注射用交联透明质酸钠凝胶项目目前正在技术审评阶段,已进行的检查均已通过,审评仍在继续。再次感谢您对键凯科技的关注。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062416441995d1d3b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062416441995d1d3b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2445047074","title":"键凯科技:翰森制药子公司江苏豪森药业集团有限公司是公司客户","url":"https://stock-news.laohu8.com/highlight/detail?id=2445047074","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445047074?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:31","pubTimestamp":1719217878,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问 信达生物、翰森制药与贵公司有合作吗?键凯科技(688356.SH)6月24日在投资者互动平台表示,翰森制药子公司江苏豪森药业集团有限公司是公司客户,与该客户的合作情况请参见招股说明书、定期报告的公开披露情况。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062416314095d1c899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062416314095d1c899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","03692","BK0229"],"gpt_icon":0},{"id":"2445704734","title":"6月24日键凯科技跌6.33%,大成中证1000指数增强发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445704734","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445704734?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:24","pubTimestamp":1719217469,"startTime":"0","endTime":"0","summary":"证券之星消息,6月24日键凯科技跌6.33%,收盘报63.18元,换手率1.14%,成交量6917.0手,成交额4471.73万元。重仓键凯科技的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家;过去90天内机构目标均价为100.0。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为大成中证1000指数增强发起式A。大成中证1000指数增强发起式A目前规模为0.89亿元,最新净值0.835,较上一交易日下跌0.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400020646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399852","159845","688356","BK0229","000852.SH","000001.SH"],"gpt_icon":0},{"id":"2445738381","title":"6月21日键凯科技涨6.89%,大成中证1000指数增强发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445738381","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445738381?lang=zh_cn&edition=full","pubTime":"2024-06-21 16:14","pubTimestamp":1718957687,"startTime":"0","endTime":"0","summary":"证券之星消息,6月21日键凯科技涨6.89%,收盘报67.45元,换手率1.73%,成交量1.05万手,成交额6930.76万元。重仓键凯科技的公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家;过去90天内机构目标均价为100.0。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为大成中证1000指数增强发起式A。大成中证1000指数增强发起式A目前规模为0.89亿元,最新净值0.8357,较上一交易日下跌1.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062116161895c8ab5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062116161895c8ab5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399852","000852.SH","159845","BK0229","000001.SH","688356"],"gpt_icon":0},{"id":"2442664303","title":"键凯科技:注射用交联透明质酸钠凝胶项目正在技术审评阶段,注射用透明质酸钠复合溶液项目临床入组已完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2442664303","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442664303?lang=zh_cn&edition=full","pubTime":"2024-06-11 18:24","pubTimestamp":1718101452,"startTime":"0","endTime":"0","summary":"键凯科技 披露投资者关系活动记录表显示,其注射用交联透明质酸钠凝胶项目目前正在技术审评阶段,已进行的检查均已通过,审评仍在继续,注册证预计获得时间还无法确定。注射用透明质酸钠复合溶液项目临床入组已经完成,正处于随访阶段。公司计划首先取得注射用交联透明质酸钠凝胶项目和注射用透明质酸钠复合溶液项目两款产品的批件,未来可能基于这两款产品开发更多功能性 医疗器械 产品线。未来不会自建销售队伍,具体销售模式仍在评估。此外,公司正在开发新型的三组分脂质纳米递送系统,具有自主 知识产权 优势,与 合成生物 学相关的核酸药物领域的发展是公司药物递送平台的新应用场景。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061118405695a48c78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061118405695a48c78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-26","address":"北京市海淀区西小口路66号中关村东升科技园·北领地C-1楼3层306、308、310、311(东升地区)","stockEarnings":[{"period":"1week","weight":-0.0337},{"period":"1month","weight":-0.1505},{"period":"3month","weight":-0.2617},{"period":"6month","weight":-0.3321},{"period":"1year","weight":-0.4387},{"period":"ytd","weight":-0.4567}],"companyName":"北京键凯科技股份有限公司","boardCode":"AI0026","perCapita":"11943股","boardName":"化学原料和化学制品制造业","registeredCapital":"6061万元","compareEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.0276},{"period":"3month","weight":-0.0425},{"period":"6month","weight":0.0032},{"period":"1year","weight":-0.0786},{"period":"ytd","weight":-0.02}],"survey":" 北京键凯科技股份有限公司主要从事医用药用聚乙二醇及其活性衍生物的研发、生产和销售。公司主要产品为医用药用聚乙二醇及其活性衍生物。公司在聚乙二醇及其活性衍生物研发、生产、医药领域应用等技术领域处于国内领先地位,是国内外为数不多能进行高纯度和低分散度的医用药用聚乙二醇及活性衍生物工业化生产的公司之一,填补了国内长期缺乏规模化生产高质量的医用药用聚乙二醇及其衍生物这一空白,是全球市场的主要新兴参与者。","serverTime":1721755293479,"listedPrice":41.18,"stockholders":"5075人(较上一季度减少3.97%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"键凯科技(688356)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供键凯科技(688356)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"键凯科技,688356,键凯科技股票,键凯科技股票老虎,键凯科技股票老虎国际,键凯科技行情,键凯科技股票行情,键凯科技股价,键凯科技股市,键凯科技股票价格,键凯科技股票交易,键凯科技股票购买,键凯科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"键凯科技(688356)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供键凯科技(688356)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}